Financing, Equity Capital Markets

Oyster Point Pharma, Inc.

10/19
|
$92.0 Million
Piper Sandler served as bookrunner for Oyster Point Pharma, Inc. on its initial public offering
Sub-Type
IPO
Sub-Sector
Biopharma